Search results
The DIY Medicine Movement - WHYY
WHYY· 6 minutes agoWe look at the DIY medicine movement, and what’s prompting a growing number of patients to experiment with treatments on their own.
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
Zacks via Yahoo Finance· 3 hours agoFor the deal, AbbVie will pay $150 million in upfront and near-term milestone payments to FutureGen,...
Insider Selling: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) CEO Sells 9,064 Shares of Stock
ETF DAILY NEWS· 7 hours agoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) CEO Leonard S. Schleifer sold 9,064 shares of the company’s stock in a transaction on Tuesday, June 11th. Following ...
Enveda raises $55M to combine ancient remedies with AI for drug discovery | TechCrunch
TechCrunch· 6 hours agoAspirin is just one example of a medicine derived from natural sources. In fact, the World Health...
The Supreme Court upholds access to mifepristone in a unanimous decision on abortion
Fortune via Yahoo Finance· 3 hours agoThe case, FDA v. Alliance for Hippocratic Medicine, had rallied the pharmaceutical industry, which...
Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.
The Wall Street Journal· 14 hours agoJust a year and a half later, it was approved as Zepbound for chronic weight management. “I’m pretty...
Eli Lilly doubles investment to $2 billion in Concord pharma facility ahead of opening
Charlotte Observer via Yahoo Finance· 6 hours agoThe pharmaceutical giant is hosting a ribbon-cutting ceremony and tour Friday morning of the drug...
Cranbury Pharmaceuticals Receives FDA Approval for First Generic Version of Emflaza Oral Suspension
New Jersey Business Magazine· 1 day agoCranbury Pharmaceuticals, a wholly-owned subsidiary of Tris Pharma, today announced the U.S. Food...
Q2 2024 EPS Estimates for Longboard Pharmaceuticals, Inc. Cut by Analyst (NASDAQ:LBPH)
ETF DAILY NEWS· 15 hours agoLongboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Free Report) – Equities research analysts at B. Riley dropped their Q2 2024 EPS estimates for Longboard Pharmaceuticals ...
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Short Interest Update
ETF DAILY NEWS· 12 hours agoAgios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) saw a significant drop in short interest in May. As of May 31st, there was short interest totalling 4,470,000 shares ...
